Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Displacement bone marrow transplantation for some inborn errors.

J R Hobbs1

  • 1Westminster Bone Marrow Team, Charing Cross and Westminster Medical School, Westminster Hospital, London, UK.

Journal of Inherited Metabolic Disease
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone Marrow Transplantation.

Bristol medico-chirurgical journal (1963)·2017
Same author

Immunological studies in chronic granulomatous candidiasis and the effect of treatment with dialysable transfer factor.

Archives of disease in childhood·2010
Same author

Congestive Cardiac Failure due to Secondary Amyloidosis.

Proceedings of the Royal Society of Medicine·2010
Same author

Further aspects of human immunoglobulin A deficiency.

Annals of clinical biochemistry·2007
Same author

Monellin (MNEI) at 1.15 A resolution.

Acta crystallographica. Section F, Structural biology and crystallization communications·2007
Same author

Guanine specific binding at a DNA junction formed by d[CG(5-BrU)ACG](2) with a topoisomerase poison in the presence of Co(2+) ions.

Biochemistry·2000
Same journal

Biallelic Loss-Of-Function Variant in ATP5ME Is Associated With Severe and Early Onset Oxidative Phosphorylation Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
See all related articles

Bone marrow transplants have evolved to treat genetic immunodeficiencies using alternative donors and immunoprophylaxis. This approach successfully corrects many fatal genetic diseases by replacing abnormal host cells or delivering functional components.

Area of Science:

  • Hematology
  • Immunology
  • Genetics

Background:

  • Early bone marrow transplants for genetic immunodeficiencies required matched sibling donors, limiting patient access.
  • Advancements in induction protocols allowed for alternative donors, including family members and unrelated volunteers.

Purpose of the Study:

  • To evaluate the evolution and efficacy of donor bone marrow transplantation (DBMT) with immunoprophylaxis for genetic diseases.
  • To assess the potential of DBMT to correct genetic defects by cell replacement or component transfer.

Main Methods:

  • Utilizing donor cell markers and enzyme analysis to measure engraftment extent.
  • Implementing immunoprophylaxis to prevent rejection by residual host immune cells.
  • Developing strategies for 100% donor-type marrow engraftment for complete immune tolerance.

Related Experiment Videos

Main Results:

  • Over 10 years, DBMT successfully corrected more than 40 fatal genetic diseases and partially corrected seven others.
  • Inadequate delivery of donor-derived components to specific tissues (heart, cartilage, brain) was observed in five cases.
  • The principles of DBMT show potential for treating approximately 40 additional genetic diseases lacking alternative therapies.

Conclusions:

  • Donor bone marrow transplantation combined with immunoprophylaxis represents a significant advancement in treating genetic immunodeficiencies.
  • While effective for many conditions, challenges remain in ensuring adequate component delivery to all affected tissues.
  • DBMT offers a promising therapeutic avenue for a wide range of genetic disorders.